The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and BPC 157 Benefits: Heal & Thrive in 2025 How did BPC 157 become the wellness industry's star peptide? BPC 157: What Research Shows (and What It Doesn't) Meeting Point Health FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York